ACADIA Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACAD Nasdaq 2834 https://acadia.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ACADIA Pharmaceuticals Inc.

Acadia Terminates Painkiller, Cancer Candidate After Disappointing Data - Aug 9th, 2022 5:24 pm
Acadia's (ACAD) Q2 Earnings & Revenues Surpass Estimates - Aug 9th, 2022 3:06 pm
Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Tops Revenue Estimates - Aug 8th, 2022 9:35 pm
Acadia Pharmaceuticals Reports Second Quarter 2022 Financial Results - Aug 8th, 2022 8:05 pm
FDA Asks For Additional Study For Acadia's Pimavanserin In Alzheimer's-Associated Delusions - Aug 5th, 2022 11:55 am
UPDATE 1-U.S. FDA declines to approve expanded use of Acadia's antipsychotic drug - Aug 5th, 2022 3:39 am
Acadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis - Aug 5th, 2022 3:05 am
Acadia Pharmaceuticals (ACAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Aug 1st, 2022 2:01 pm
Investors five-year losses grow to 52% as the stock sheds US$212m this past week - Jul 27th, 2022 12:23 pm
Acadia Pharmaceuticals to Announce Second Quarter 2022 Financial Results on August 8, 2022 - Jul 25th, 2022 8:05 pm
Acadia (ACAD) Files an NDA for Its Rett Syndrome Candidate - Jul 19th, 2022 3:22 pm
Acadia Pharmaceuticals Submits New Drug Application to the U.S. FDA for Trofinetide for the Treatment of Rett Syndrome - Jul 18th, 2022 8:07 pm
Acadia (ACAD) Down More Than 30% in Past 3 Months: Here's Why - Jul 8th, 2022 3:14 pm
Why Acadia Pharmaceuticals Stock Is Crashing Today - Jun 21st, 2022 4:07 pm
Why Acadia Pharma Shares Are Plunging Today - Jun 21st, 2022 12:27 pm
Acadia's stock down 30% in premarket trading on Tuesday after last week's FDA committee vote - Jun 21st, 2022 11:56 am
Acadia Pharmaceuticals Announces Outcome of FDA Advisory Committee for NUPLAZID® (pimavanserin) for the Treatment of Alzheimer’s Disease Psychosis - Jun 18th, 2022 12:00 am
Acadia Pharmaceuticals stock halted for FDA panel to review treatment for hallucinations stemming from Alzheimer's disease psychosis - Jun 17th, 2022 11:14 am
Acadia Pharmaceuticals Stock Trading Halted Today - Jun 17th, 2022 11:05 am
HC Wainwright Sees Opportunity For Acadia's Alzheimer's Candidate - Jun 16th, 2022 7:42 pm